Project Details
Created for Generate Biomedicines, this mechanism of action animation illustrates how GB-0669, an AI-designed monoclonal antibody, binds the conserved S2 stem helix of the SARS-CoV-2 spike protein to inhibit viral fusion with host cells. The program demonstrates Generate Biomedicines' approach to targeting historically difficult-to-drug viral epitopes.
Client: Generate Biomedicines
Created at: Microverse Studios
Role: Modeling, animation, lighting, texturing, rendering, compositing, and editing
Year: 2023
Featured In
CBS '60 Minutes' feature on Generate Biomedicines
Back to Top